Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2012 (2012), Article ID 309417, 9 pages
Research Article

Cytoreductive Surgery Plus Hyperthermic Perioperative Chemotherapy for Selected Patients with Peritoneal Metastases from Colorectal Cancer: A New Standard of Care or an Experimental Approach?

Washington Cancer Institute, Program in Peritoneal Surface Malignancy, Washington, DC 20010, USA

Received 5 April 2012; Accepted 16 May 2012

Academic Editor: Pompiliu Piso

Copyright © 2012 Paul H. Sugarbaker. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [13 citations]

The following is the list of published articles that have cited the current article.

  • T. Shimizu, H. Sonoda, S. Murata, K. Takebayashi, H. Ohta, T. Miyake, E. Mekata, H. Shiomi, S. Naka, and T. Tani, “Hyperthermic intraperitoneal chemotherapy using a combination of mitomycin C,5-fluorouracil, and oxaliplatin in patients at high risk of colorectal peritoneal metastasis: A Phase I clinical study,” European Journal of Surgical Oncology (EJSO), vol. 40, no. 5, pp. 521–528, 2014. View at Publisher · View at Google Scholar
  • Flávio D. Sabino, Carlos Frederico F. Campos, Carlos Eduardo R. Caetano, Marcele Nogueira S. Trotte, Albanita V. Oliveira, and Ruy G. Marques, “Effects of TachoSil® and 5-fluorouracil on colonic anastomotic healing,” Journal of Surgical Research, 2014. View at Publisher · View at Google Scholar
  • Michael S. Leapman, Ghalib Jibara, Parissa Tabrizian, Bernardo Franssen, Ming-Jim Yang, Anya Romanoff, Simon J. Hall, Michael Palese, Umut Sarpel, Spiros Hiotis, and Daniel Labow, “Genitourinary Resection at the Time of Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis Is Not Associated with Increased Morbidity or Worsened Oncologic Outcomes: A Case-matched Study,” Annals of Surgical Oncology, vol. 21, no. 4, pp. 1153–1158, 2014. View at Publisher · View at Google Scholar
  • George R. Dakwar, Elisa Zagato, Joris Delanghe, Sabrina Hobel, Achim Aigner, Hannelore Denys, Kevin Braeckmans, Wim Ceelen, Stefaan C. De Smedt, and Katrien Remaut, “Colloidal stability of nano-sized particles in the peritoneal fluid: Towards optimizing drug delivery systems for intraperitoneal therapy,” Acta Biomaterialia, 2014. View at Publisher · View at Google Scholar
  • Mehraneh D. Jafari, Wissam J. Halabi, Michael J. Stamos, Vinh Q. Nguyen, Joseph C. Carmichael, Steven D. Mills, and Alessio Pigazzi, “Surgical Outcomes of Hyperthermic Intraperitoneal Chemotherapy Analysis of the American College of Surgeons National Surgical Quality Improvement Program,” Jama Surgery, vol. 149, no. 2, pp. 170–175, 2014. View at Publisher · View at Google Scholar
  • Tomoharu Shimizu, Satoshi Murata, Hiromichi Sonoda, Eiji Mekata, Hiroyuki Ohta, Katsushi Takebayashi, Tohru Miyake, and Tohru Tani, “Hyperthermic intraperitoneal chemotherapy with mitomycin C and 5-fluorouracil in patients at high risk of peritoneal metastasis from colorectal cancer: A preliminary clinical study,” Molecular and Clinical Oncology, vol. 2, no. 3, pp. 399–404, 2014. View at Publisher · View at Google Scholar
  • T.R. van Oudheusden, S.W. Nienhuijs, M.D. Luyer, G.A. Nieuwenhuijzen, V.E. Lemmens, H.J. Rutten, and I.H. de Hingh, “Incidence and treatment of recurrent disease after cytoreductive surgery and intraperitoneal chemotherapy for peritoneally metastasized colorectal cancer: a systematic review,” European Journal of Surgical Oncology (EJSO), 2015. View at Publisher · View at Google Scholar
  • T. R. van Oudheusden, H. J. Braam, M. D. P. Luyer, M. J. Wiezer, B. van Ramshorst, S. W. Nienhuijs, and I. H. J. T. de Hingh, “Peritoneal Cancer Patients Not Suitable for Cytoreductive Surgery and HIPEC During Explorative Surgery: Risk Factors, Treatment Options, and Prognosis,” Annals Of Surgical Oncology, vol. 22, no. 4, pp. 1236–1242, 2015. View at Publisher · View at Google Scholar
  • Maurizio Cardi, Paolo Sammartino, Valentina Mingarelli, Simone Sibio, Fabio Accarpio, Daniele Biacchi, Daniela Musio, Bianca Sollazzo, and Angelo Di Giorgio, “Cytoreduction and HIPEC in the treatment of “unconventional” secondary peritoneal carcinomatosis,” World Journal of Surgical Oncology, vol. 13, no. 1, 2015. View at Publisher · View at Google Scholar
  • James Oyeniyi, Jumin Wu, Diane Liu, James C. Yao, Holly Green, Karen Albritton, Winston Huh, and Andrea Hayes-Jordan, “Adolescents and Young Adults (AYA) with Colon Rectal Carcinoma(CRC) Including Treatment of Carcinomatosis Using Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC),” The American Journal of Surgery, 2015. View at Publisher · View at Google Scholar
  • Paul H. Sugarbaker, “Improving oncologic outcomes for colorectal cancer at high risk for local-regional recurrence with novel surgical techniques,” Expert Review Of Gastroenterology & Hepatology, vol. 10, no. 2, pp. 205–213, 2016. View at Publisher · View at Google Scholar
  • Madeddu, Marini, Manca, Giovanni Mantovani, Orgiano, Pani, and Astara, “The role of “closed abdomen” hyperthermic intraperitoneal chemotherapy (HIPEC) in the palliative treatment of neoplastic ascites from peritoneal carcinomatosis: report of a single-center experience,” Supportive Care in Cancer, vol. 24, no. 10, pp. 4293–4299, 2016. View at Publisher · View at Google Scholar
  • C. E. L. Klaver, H. Groenen, D. G. Morton, S. Laurberg, W. A. Bemelman, and P. J. Tanis, “Recommendations and consensus on the treatment of peritoneal metastases of colorectal origin: a systematic review of national and international guidelines,” Colorectal Disease, vol. 19, no. 3, pp. 224–236, 2017. View at Publisher · View at Google Scholar